Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Serum Brain-Derived Neurotrophic Factor as a Predictor of Incident Dementia—Reply

Serum Brain-Derived Neurotrophic Factor as a Predictor of Incident Dementia—Reply Letters Corresponding Author: Hassan Fathallah-Shaykh, MD, PhD, University of Author Affiliation: Division of Clinical Neuroscience, Chiba University Center Alabama at Birmingham, Department of Neurology, 150 3rd Ave S, FOT 1020, for Forensic Mental Health, Chiba, Japan. Birmingham, AL 35295-2410 (hfathall@uab.edu). Corresponding Author: Kenji Hashimoto, PhD, Division of Clinical Conflict of Interest Disclosures: None reported. Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, Japan (hashimoto@faculty.chiba-u.jp). 1. Love MN, Fathallah-Shaykh H. Network for excellence in Neuroscience Clinical Trials: NeuroNEXT. JAMA Neurol. 2013;70(10):1227-1228. Conflict of Interest Disclosures: Dr Hashimoto is a holder of the patents “Diagnostic and examination method for eating disorder” (US 7,754,434 B2) and doi:10.1001/jamaneurol.2013.3663. “Diagnostic agent for ischemic heart disease risk group” (US 2013/0310321A1), which pertain to the measurement of brain-derived neurotrophic factor as a biomarker. In addition, Dr Hashimoto has served as a scientific consultant to Serum Brain-Derived Neurotrophic Factor Astellas and Taisho, and he has received research support from Abbvie, Dainippon Sumitomo, Otsuka, and Taisho. as a Predictor of Incident Dementia To the Editor I read with great interest the article by Weinstein 1. Weinstein G, Beiser AS, Choi SH, et al. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Neurology American Medical Association

Serum Brain-Derived Neurotrophic Factor as a Predictor of Incident Dementia—Reply

JAMA Neurology , Volume 71 (5) – May 1, 2014

Loading next page...
 
/lp/american-medical-association/serum-brain-derived-neurotrophic-factor-as-a-predictor-of-incident-FVkCEyHFr0
Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6149
eISSN
2168-6157
DOI
10.1001/jamaneurol.2014.215
pmid
24818683
Publisher site
See Article on Publisher Site

Abstract

Letters Corresponding Author: Hassan Fathallah-Shaykh, MD, PhD, University of Author Affiliation: Division of Clinical Neuroscience, Chiba University Center Alabama at Birmingham, Department of Neurology, 150 3rd Ave S, FOT 1020, for Forensic Mental Health, Chiba, Japan. Birmingham, AL 35295-2410 (hfathall@uab.edu). Corresponding Author: Kenji Hashimoto, PhD, Division of Clinical Conflict of Interest Disclosures: None reported. Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, Japan (hashimoto@faculty.chiba-u.jp). 1. Love MN, Fathallah-Shaykh H. Network for excellence in Neuroscience Clinical Trials: NeuroNEXT. JAMA Neurol. 2013;70(10):1227-1228. Conflict of Interest Disclosures: Dr Hashimoto is a holder of the patents “Diagnostic and examination method for eating disorder” (US 7,754,434 B2) and doi:10.1001/jamaneurol.2013.3663. “Diagnostic agent for ischemic heart disease risk group” (US 2013/0310321A1), which pertain to the measurement of brain-derived neurotrophic factor as a biomarker. In addition, Dr Hashimoto has served as a scientific consultant to Serum Brain-Derived Neurotrophic Factor Astellas and Taisho, and he has received research support from Abbvie, Dainippon Sumitomo, Otsuka, and Taisho. as a Predictor of Incident Dementia To the Editor I read with great interest the article by Weinstein 1. Weinstein G, Beiser AS, Choi SH, et al. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham

Journal

JAMA NeurologyAmerican Medical Association

Published: May 1, 2014

References